All Type of News
[Focus] Sales policy of new Sanofi-Aventis company attracts keen interest
As Sanofi-Synthelabo and Aventis SA plans to create the world' third largest pharmaceutical company on August 20 after Sanofi increased an earlier hostile bid for Aventis, domestic drug wholesalers and pharmaceutical ...
Ex-KFDA head warning MOHW's domination on policy.
Chief Commissioner Shim Chang-goo of KFDA vindicated his resignation in the press interview on Aug. 12 as saying that for an efficient performance of the KFDA's activity as an independent agency from the MOHW, the KFD...
KFDA's Seoul Regional Agency gets good marks in public ratings
Te Seoul Regional Agency of the KFDA says it surveyed the ratings in terms of public confidence in the agency based on its telephone interview of a total of randomly selected 150 businessmen and private individuals in...
"Aromafloria" herbal brand growing popular in pharmacy market.
A herbal aroma brand "Aromafloria" supplied by Ssesa (President: Jang Eun-hee) and originally manufactured and distributed by an American company, California Fragrance Inc. was getting popular in the retail pharmacy m...
Some pharmaceutical makers showing brisk sales in first half
Three leading pharmaceutical firms Kwangdong, Hanmi and Dong-A, saw their sales revenue surge in the first half of this year despite the lengthy slump for the domestic pharmaceutical industry.
The majority of loca...
KFDA to exclude new drugs in re-examination from list of items subject to notification
The Korea Food and Drug Administration announced on August 11 that new drugs in the process of re-examination will be excluded from the list of notification items whose safety and efficacy has been already established...
MOHW to legislate relief fund for drug adverse reaction damages.
Minister Kim Keun-tae of MOHW indicated an earlier legislation move legally to establish a relief fund rapidly to compensate drug adverse reaction damages. At the same time, he intended to induce more people to take p...
Exclusive drug purchase card system under consideration.
In an attempt to enhance the drug trade quality and credit payment efficiency the MOHW is going to make a survey against the drug industries, wholesalers and medical institutions about the introduction of so called "E...
New drug-related administration to be reformed
The Korea Food and Drug Administration is contemplating a series of new measures designed to ameliorate new drugs-related regulations, said Lee Hee-sung, director-general of Drug Safety Division of the KFDA, in a repo...
DUR system likely to be further promoted
With belated move of the Korea Food and Drug Administration to ban 75 companies from producing and selling 167 products containing phenylpropanolamine (PPA), there is a social consensus on safer use of drugs and this ...
